Approved Drugs Containing Thiols as Inhibitors of Metallo-beta-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Klingler, F.M., Wichelhaus, T.A., Frank, D., Cuesta-Bernal, J., El-Delik, J., Muller, H.F., Sjuts, H., Gottig, S., Koenigs, A., Pos, K.M., Pogoryelov, D., Proschak, E.(2015) J Med Chem 58: 3626-3630
- PubMed: 25815530 
- DOI: https://doi.org/10.1021/jm501844d
- Primary Citation of Related Structures:  
5A5Z - PubMed Abstract: 
Resistance to β-lactam antibiotics can be mediated by metallo-β-lactamase enzymes (MBLs). An MBL inhibitor could restore the effectiveness of β-lactams. We report on the evaluation of approved thiol-containing drugs as inhibitors of NDM-1, VIM-1, and IMP-7. Drugs were assessed by a novel assay using a purchasable fluorescent substrate and thermal shift. Best compounds were tested in antimicrobial susceptibility assay. Using these orthogonal screening methods, we identified drugs that restored the activity of imipenem.
Organizational Affiliation: 
§Institute of Medical Microbiology and Infection Control, Paul-Ehrlich-Straße 40, 60596 Frankfurt, Germany.